Clinical ResearchCosts of Transradial Percutaneous Coronary Intervention
Key Words
Abbreviations and Acronyms
Cited by (0)
Supported by an unrestricted research grant from Terumo Medical Corporation. Dr. Amin has reported that he is a KM1 scholar and is funded by a comparative effectiveness research career development award from the National Center for Advancing Translational Sciences Clinical and Translational Science Award (CTSA) program (UL1TR000448, KL2TR000450, and TL1TR000449) and the National Cancer Institute (1KM1CA156708-01). Dr. Safley has received compensation paid directly to the Saint Luke’s Hospital Foundation of Kansas City for his research activities from Merck & Co, Inc.. Drs. Giersiefen and Bremer are employees of ViTA Solutions, a product-independent consulting division of The Medicines Company, and they participated in the study design, data collection, and review of the manuscript. Dr. Hamon has received consulting fees from The Medicines Company. Dr. Baklanov has received research grants from Blue Cross Blue Shield of Kansas City and consulting fees from Heart.org. Dr. Wohns has served on the Speakers’ Bureaus/advisory boards of Terumo and The Medicines Company. Dr. Mathias has served on the Speakers’ Bureaus for Terumo Medical and Medtronic; and has received speakers’ honoraria from Terumo Medical, The Medicines Company, and Medtronic. Dr. Applegate has received research grants from Abbott Vascular, ACIST Medical Systems, St. Jude Medical, and Terumo Medical; has served on the advisory board of Abbott Vascular; and has received honoraria from Abbott Vascular. Dr. Cohen has received institutional research grants from Medtronic, Boston Scientific, Abbott Vascular, Edwards Lifesciences, Biomet, Inc., Eli Lilly, Daiichi-Sankyo, AstraZeneca; and has received consulting fees from Medtronic, Abbott Vascular, and Eli Lilly. Dr. Marso has received funding paid directly to the Saint Luke’s Hospital Foundation of Kansas City for research activities from The Medicines Company, Novo Nordisk, Amylin Pharmaceuticals, Volcano Corporation, St. Jude Medical, and Terumo Medical. All other authors have reported that they have no conflicts relevant to the contents of this paper to disclose.